Publications Guest User Publications Guest User

Reviewing the 2019 Niagara Investment Summit, Day 2

Picking up where we left off last week, the second day of the 2019 Niagara Investment Summit (February 20th-22nd, 2019) continued on the first day’s theme: bringing together CEOs and senior executives from Canada’s most innovative health science companies with investors and strategics in beautiful Niagara-on-the-Lake.

Read More
Publications Guest User Publications Guest User

Reviewing the 2019 Niagara Investment Summit, Day 1

The OBIO 2019 Niagara Investment Summit, held in historic Niagara-on-the-Lake from February 20th through 22nd, brought together CEOs and senior executives representing Canadian health science companies from Halifax to Vancouver, global investors and venture capitalists, and health science industry leaders for two panels of company presentations, one-on-one meetings, panel discussions and keynote speakers.

Read More
OBIO News, Press Releases Guest User OBIO News, Press Releases Guest User

OBIO Opens 2019 Niagara Investment Summit, Connecting Canada’s Most Promising Innovations with Leading Global Investors

OBIO is proud to announce the opening of the 2019 Niagara Investment Summit in Niagara-on-the-Lake, Ontario, on February 21-22, 2019. The 2019 Niagara Investment Summit will feature over 30 of Canada’s most promising innovative health science companies meeting with more than 30 US and global investors and VCs in Niagara-on-the-Lake to propel investment in Canada’s health science industry.

Read More
Publications Guest User Publications Guest User

Reviewing OBIO’s Cross-Border Investing Panel

OBIO’s recent Cross Border Investing panel on January 31, 2019, hosted by Osler Hoskin & Harcourt LLP and moderated by Gail Garland (CEO, OBIO), featured David Young (CEO, Kisoji Biotechnology), Mike Cooke (CEO, AmacaThera) and Chad Bayne (Partner, Osler) answering questions on their experiences raising money for Canadian companies from international investors.

Read More